NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,900 | -46.0% | 3,000 | -29.4% | 0.03% | -39.2% |
| Q2 2023 | $68,298 | +30.8% | 4,250 | +41.7% | 0.05% | +24.4% |
| Q1 2023 | $52,230 | +76.6% | 3,000 | -6.2% | 0.04% | +86.4% |
| Q4 2022 | $29,568 | +28.6% | 3,200 | +18.5% | 0.02% | +10.0% |
| Q3 2022 | $23,000 | +4.5% | 2,700 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $22,000 | +46.7% | 2,700 | +125.0% | 0.02% | +80.0% |
| Q1 2022 | $15,000 | -63.4% | 1,200 | 0.0% | 0.01% | -61.5% |
| Q4 2021 | $41,000 | -71.5% | 1,200 | -59.8% | 0.03% | -75.5% |
| Q3 2021 | $144,000 | +15.2% | 2,988 | +8.0% | 0.11% | +15.2% |
| Q2 2021 | $125,000 | +594.4% | 2,767 | +641.8% | 0.09% | +557.1% |
| Q1 2021 | $18,000 | +5.9% | 373 | +18.0% | 0.01% | -6.7% |
| Q4 2020 | $17,000 | -79.5% | 316 | -85.9% | 0.02% | -80.0% |
| Q3 2020 | $83,000 | +1085.7% | 2,249 | +848.9% | 0.08% | +837.5% |
| Q2 2020 | $7,000 | – | 237 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |